MedTrace Logo

Study of Outcomes of Radiofrequency Ablation of Lung Tumors

NCT00280189 · Status: SUSPENDED · Type: OBSERVATIONAL · Enrollment: 72

Last updated 2026-04-14

No results posted yet for this study

Summary

The purpose of this study is to assess short and long term outcomes after radiofrequency ablation (RFA) of pulmonary malignancies in patients who are not candidates for surgical resection. This study will evaluate the efficacy of RFA for the treatment of lung tumors by assessing its impact on local tumor control, progression free survival, overall survival, dyspnea score and quality of life (QOL).

Conditions

  • NSCLC
  • Pulmonary Metastases

Interventions

PROCEDURE

Radiofrequency ablation of pulmonary malignancies

Radiofrequency ablation is an inpatient procedure typically requiring one overnight stay in the hospital.

BEHAVIORAL

Quality of life assessment

Quality of life assessment is administered prior to the Radiofrequency ablation procedure and every 3 months for 1 year following the procedure.

BEHAVIORAL

Assessment of pain

Pain scores are obtained prior to the procedure, daily X 7 starting on the day of surgery, and then every 3 months for 1 year.

Sponsors & Collaborators

  • RITA Medical Systems

    collaborator INDUSTRY

  • University of Pittsburgh

    lead OTHER

Principal Investigators

  • James Luketich, MD · UPMC - Department of Cardiothoracic Surgery

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-09-30
Primary Completion
2027-03-31
Completion
2028-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00280189 on ClinicalTrials.gov